1-6 of 6
Akira Shimatsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639

Noriko Satoh-Asahara, MD, PHD, Akira Shimatsu, MD, PHD, Hiromichi Wada, MD, PHD, Takayoshi Suganami, MD, PHD, Koji Hasegawa, MD, PHD, Yoshihiro Ogawa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(7):e110
https://doi.org/10.2337/dc13-0376
Published: 12 June 2013
View article titled, Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639
Open the PDF for Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 in another window
Journal Articles

Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia

Noriko Satoh-Asahara, MD, Akira Shimatsu, MD, Yousuke Sasaki, BSC, Hidenori Nakaoka, PHD, Akihiro Himeno, MD, Mayu Tochiya, MD, Shigeo Kono, MD, Tomohide Takaya, PHD, Koh Ono, MD, Hiromichi Wada, MD, Takayoshi Suganami, MD, Koji Hasegawa, MD, Yoshihiro Ogawa, MD
Journal: Diabetes Care
Diabetes Care 2012;35(12):2631–2639
https://doi.org/10.2337/dc12-0269
Published: 14 November 2012
View article titled, Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia
Open the PDF for Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia in another window
Includes: Supplementary data
Journal Articles

Unbalanced M1/M2 Phenotype of Peripheral Blood Monocytes in Obese Diabetic Patients: Effect of pioglitazone

Noriko Satoh, MD, PHD, Akira Shimatsu, MD, PHD, Akihiro Himeno, MD, Yousuke Sasaki, BSC, Hajime Yamakage, BSC, Kazunori Yamada, MD, PHD, Takayoshi Suganami, MD, PHD, Yoshihiro Ogawa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(1):e7
https://doi.org/10.2337/dc09-1315
Published: 01 January 2010
View article titled, Unbalanced M1/M2 Phenotype of Peripheral Blood Monocytes in Obese Diabetic Patients: <subtitle>Effect of pioglitazone</subtitle>
Open the PDF for Unbalanced M1/M2 Phenotype of Peripheral Blood Monocytes in Obese Diabetic Patients: <subtitle>Effect of pioglitazone</subtitle> in another window
Journal Articles

Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome

Noriko Satoh, MD, PHD, Akira Shimatsu, MD, PHD, Kazuhiko Kotani, MD, PHD, Naoki Sakane, MD, PHD, Kazunori Yamada, MD, PHD, Takayoshi Suganami, MD, PHD, Hideshi Kuzuya, MD, PHD, Yoshihiro Ogawa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(1):144–146
https://doi.org/10.2337/dc06-1179
Published: 01 January 2007
View article titled, Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome
Open the PDF for Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome in another window
Journal Articles

Leptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients

Noriko Satoh, MD, PHD, Mitsuhide Naruse, MD, PHD, Takeshi Usui, MD, PHD, Tetsuya Tagami, MD, PHD, Takayoshi Suganami, MD, PHD, Kazunori Yamada, MD, PHD, Hideshi Kuzuya, MD, PHD, Akira Shimatsu, MD, PHD, Yoshihiro Ogawa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(10):2488–2490
https://doi.org/10.2337/diacare.27.10.2488
Published: 01 October 2004
View article titled, Leptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients
Open the PDF for Leptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients in another window
Journal Articles

Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect

Noriko Satoh, MD, PHD, Yoshihiro Ogawa, MD, PHD, Takeshi Usui, MD, PHD, Tetsuya Tagami, MD, PHD, Shigeo Kono, MD, PHD, Hiroko Uesugi, MD, PHD, Hiroyuki Sugiyama, MD, PHD, Akira Sugawara, MD, PHD, Kazunori Yamada, MD, PHD, Akira Shimatsu, MD, PHD, Hideshi Kuzuya, MD, PHD, Kazuwa Nakao, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(9):2493–2499
https://doi.org/10.2337/diacare.26.9.2493
Published: 01 September 2003
View article titled, Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect
Open the PDF for Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect in another window